Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-11-14 | 2022-11-14 |
| Drug Identification Number | 02329271 | 02329271 |
| Brand name | OCTREOSCAN | OCTREOSCAN |
| Common or Proper name | Octreoscan | Octreoscan |
| Company Name | CURIUM CANADA INC | CURIUM CANADA INC |
| Ingredients | PENTETREOTIDE INDIUM IN 111 CHLORIDE | PENTETREOTIDE INDIUM IN 111 CHLORIDE |
| Strength(s) | 10MCG 111MBq | 10MCG 111MBq |
| Dosage form(s) | POWDER FOR SOLUTION KIT SOLUTION | POWDER FOR SOLUTION KIT SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | Vial 10 mL | Vial 10 mL |
| ATC code | V09IB | V09IB |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-11-06 | 2022-11-06 |
| Actual start date | 2022-11-06 | 2022-11-06 |
| Estimated end date | 2022-11-10 | 2022-11-10 |
| Actual end date | 2022-11-10 | 2022-11-10 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Due to a delay in production of Indium-111 raw material, there will be a 24-hour delay in the release of Octreoscan. Product scheduled for shipment on Sunday, November 6 will not be available. Due to a low yield concentration with the Indium-111 raw material, we are unable to execute production on the lot of Octreoscan. As a result, product will not be available for shipment on Monday, November 7. | Due to a delay in production of Indium-111 raw material, there will be a 24-hour delay in the release of Octreoscan. Product scheduled for shipment on Sunday, November 6 will not be available. Due to a low yield concentration with the Indium-111 raw material, we are unable to execute production on the lot of Octreoscan. As a result, product will not be available for shipment on Monday, November 7. |
| Health Canada comments |